Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece
Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:
Publication profile
google scholar
Qualifications & Experience
Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.
Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.
Research Contributions
Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.
Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.
Editorial and Advisory Roles
Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.
Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.
Notable Publications
His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.
Conclusion
Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.
Publication top notes
Patients’ preferences for headache acute and preventive treatment
Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
Headache patients in the emergency department of a Greek tertiary care hospital
OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine
Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis
Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …